BBIO
BridgeBio Pharma Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$69.41
+1.43 ▲ +2.10%
🌙 3월 13일 7:54 PM ET (한국 3/14 08:54)
$69.97
+0.56 ▲ +0.81%
| Index | RUT | P/E | - | EPS (ttm) | -3.78 | Insider Own | 14.26% | Shs Outstand | 0.19B | Perf Week | 6.2% |
| Market Cap | 13.46B | Forward P/E | 94.02 | EPS next Y | 138.74% | Insider Trans | -3.56% | Shs Float | 0.17B | Perf Month | -5.35% |
| Enterprise Value | 15.61B | PEG | - | EPS next Q | -0.68 | Inst Own | 88.72% | Short Float | 13.21% | Perf Quarter | -4.53% |
| Income | -0.72B | P/S | 26.8 | EPS this Y | 49.59% | Inst Trans | 1.57% | Short Ratio | 7.52 | Perf Half Y | 31.96% |
| Sales | 0.50B | P/B | - | EPS next 5Y | - | ROA | -78.14% | Short Interest | 21.96M | Perf YTD | -9.26% |
| Book/sh | -10.71 | P/C | 22.88 | EPS past 3/5Y | -5.07% 0.09% | ROE | - | 52W High | -18.28% ($84.94) | Perf Year | 114.83% |
| Cash/sh | 3.03 | P/FCF | - | Sales past 3/5Y | 86.3% 127.44% | ROIC | -116.04% | 52W Low | 145.05% ($28.33) | Perf 3Y | 377.7% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -32.9% | Gross Margin | 95.28% | Volatility(W/M) | 5.93% 5.42% | Perf 5Y | -2.16% |
| Dividend TTM | - | EV/Sales | 31.08 | Sales Y/Y TTM | 126.26% | Oper. Margin | -100% | ATR (14) | 3.77 | Perf 10Y | - |
| Dividend Ex-Date | - | Quick Ratio | 2.68 | EPS Q/Q | 28.78% | Profit Margin | -144.39% | RSI (14) | 49.03 | Recom | 1.3 |
| Dividend Gr. 3/5Y | - | Current Ratio | 2.77 | Sales Q/Q | 2521.18% | SMA20 | 0.77% ($68.88) | Beta | 1.16 | Target Price | $101.35 |
| Payout | - | Debt/Eq | - | Earnings | 2000000 | SMA50 | -4.96% ($73.03) | Rel Volume | 0.62 | Prev Close | $67.98 |
| Employees | 839 | LT Debt/Eq | - | EPS/Sales Surpr. | -40.17% 5% | SMA200 | 17.54% ($59.05) | Avg Volume(3M) | 2.92M | Price | $69.41 |
| IPO | 2019/6/27 | Option/Short | Yes/Yes | Trades | 18694 | Volume | 1,820,747 | Change | 2.1% |
뉴스 로딩 중...